BioInvent International AB (BOVNF)
4.70
0.00 (0.00%)
USD |
OTCM |
Nov 13, 16:00
BioInvent International Price to Book Value: 3.109 for Nov. 13, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 3.109 |
| November 12, 2024 | 3.109 |
| November 11, 2024 | 3.109 |
| November 08, 2024 | 3.109 |
| November 07, 2024 | 3.109 |
| November 06, 2024 | 3.109 |
| November 05, 2024 | 3.109 |
| November 04, 2024 | 3.109 |
| November 01, 2024 | 3.109 |
| October 31, 2024 | 3.109 |
| October 30, 2024 | 3.109 |
| October 29, 2024 | 3.109 |
| October 28, 2024 | 3.109 |
| October 25, 2024 | 3.109 |
| October 24, 2024 | 3.109 |
| October 23, 2024 | 3.109 |
| October 22, 2024 | 3.109 |
| October 21, 2024 | 3.109 |
| October 18, 2024 | 3.109 |
| October 17, 2024 | 3.109 |
| October 16, 2024 | 3.109 |
| October 15, 2024 | 3.109 |
| October 14, 2024 | 3.109 |
| October 11, 2024 | 3.109 |
| October 10, 2024 | 3.109 |
| Date | Value |
|---|---|
| October 09, 2024 | 3.109 |
| October 08, 2024 | 3.109 |
| October 07, 2024 | 3.109 |
| October 04, 2024 | 3.109 |
| October 03, 2024 | 3.109 |
| October 02, 2024 | 3.109 |
| October 01, 2024 | 3.109 |
| September 30, 2024 | 3.109 |
| September 27, 2024 | 2.991 |
| September 26, 2024 | 2.991 |
| September 25, 2024 | 2.991 |
| September 24, 2024 | 2.991 |
| September 23, 2024 | 2.991 |
| September 20, 2024 | 2.991 |
| September 19, 2024 | 2.991 |
| September 18, 2024 | 2.991 |
| September 17, 2024 | 2.991 |
| September 16, 2024 | 2.991 |
| September 13, 2024 | 2.991 |
| September 12, 2024 | 2.991 |
| September 11, 2024 | 2.991 |
| September 10, 2024 | 2.991 |
| September 09, 2024 | 2.991 |
| September 06, 2024 | 2.991 |
| September 05, 2024 | 2.991 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.153
Minimum
Jan 27 2022
7.743
Maximum
Jul 21 2020
2.850
Average
2.750
Median
Dec 04 2020
Price to Book Value Benchmarks
| Abliva AB | 2.537 |
| Oncopeptides AB | -- |
| Hansa Biopharma AB | -- |
| BioArctic AB | 17.98 |
| Camurus AB | 10.82 |
Price to Book Value Related Metrics
| PS Ratio | 84.18 |
| PEG Ratio | -0.2489 |
| Price | 4.70 |
| Earnings Yield | -12.57% |
| Market Cap | 309.28M |
| PEGY Ratio | -0.2489 |